Skip to main content
Top
Published in: Journal of Medical Case Reports 1/2021

Open Access 01-12-2021 | Computed Tomography | Case report

Clinical improvement of encapsulating peritoneal sclerosis after challenging course and 6 months of total parenteral nutrition in child with nephronophthisis: a case report

Authors: Saeed Mohammed AlZabali, Abdulkarim AlAnazi, Khawla A. Rahim, Hassan Y. Faqeehi

Published in: Journal of Medical Case Reports | Issue 1/2021

Login to get access

Abstract

Background

Encapsulating peritoneal sclerosis is a rare but potentially lethal complication of long-term peritoneal dialysis that is associated with significant morbidity and mortality. The occurrence of encapsulating peritoneal sclerosis varies worldwide, but is increased in patients maintained on peritoneal dialysis for 5–8 years. The etiology of encapsulating peritoneal sclerosis remains unidentified, and a high index of clinical suspicion is required for diagnosis.

Case presentation

We report a 5-year-old Saudi female with end-stage renal disease secondary to nephronophthisis type 2. She underwent peritoneal dialysis for 30 months, with four episodes of peritonitis. She presented with clinical signs of peritonitis. Three days later, she developed septic shock, which required pediatric intensive care unit admission. The peritoneal dialysis catheter was removed because of refractory peritonitis. Her course was complicated by small bowel perforation, and severe adhesions were revealed on abdominal ultrasound and computed tomography, consistent with a diagnosis of EPS. This finding was later confirmed by diagnostic laparotomy performed twice and complicated by recurrent abdominal wall fistula. She received total parenteral nutrition for 6 months and several courses of antibiotics. The patient received supportive treatment including nutritional optimization and treatment for infection. No other treatments, such as immunosuppression, were administered to avoid risk of infection. Following a complicated hospital course, the patient restarted oral intake after 6 months of total parenteral nutrition dependency. Her abdominal fistula resolved completely, and she was maintained on hemodialysis for few years before she received a kidney transplant.

Conclusion

When treating patients using peritoneal dialysis, it is important to consider encapsulating peritoneal sclerosis with refractory peritonitis, which is not always easy to identify, particularly if the patient has been maintained on peritoneal dialysis for less than 3 years. Early identification of encapsulating peritoneal sclerosis and appropriate conservative treatment, including nutritional optimization and treatment of infections, are essential to achieve a better prognosis.
Literature
1.
go back to reference Brown EA, Bargman J, Van Biesen W, Chang MY, Finkelstein FO, Hurst H, et al. Length of time on peritoneal dialysis and encapsulating peritoneal sclerosis—position paper for ISPD: 2017 update. Perit Dial Int. 2017;37(4):362–74.CrossRef Brown EA, Bargman J, Van Biesen W, Chang MY, Finkelstein FO, Hurst H, et al. Length of time on peritoneal dialysis and encapsulating peritoneal sclerosis—position paper for ISPD: 2017 update. Perit Dial Int. 2017;37(4):362–74.CrossRef
2.
go back to reference Kawaguchi Y, Kawanishi H, Mujais S, Topley N, Oreopoulos DG. Encapsulating peritoneal sclerosis: definition, etiology, diagnosis, and treatment. International Society for Peritoneal Dialysis Ad Hoc Committee on Ultrafiltration Management in Peritoneal Dialysis. Perit Dial Int. 2000;20(Suppl 4(May 2014)):43–55.CrossRef Kawaguchi Y, Kawanishi H, Mujais S, Topley N, Oreopoulos DG. Encapsulating peritoneal sclerosis: definition, etiology, diagnosis, and treatment. International Society for Peritoneal Dialysis Ad Hoc Committee on Ultrafiltration Management in Peritoneal Dialysis. Perit Dial Int. 2000;20(Suppl 4(May 2014)):43–55.CrossRef
3.
go back to reference de Sousa E, del Peso-Gilsanz G, Bajo-Rubio MA, Ossorio-González M, Selgas-Gutiérrez R. Encapsulating peritoneal sclerosis in peritoneal dialysis. A review and European initiative for approaching a serious and rare disease. Nefrologia. 2012;32(6):707–14.PubMed de Sousa E, del Peso-Gilsanz G, Bajo-Rubio MA, Ossorio-González M, Selgas-Gutiérrez R. Encapsulating peritoneal sclerosis in peritoneal dialysis. A review and European initiative for approaching a serious and rare disease. Nefrologia. 2012;32(6):707–14.PubMed
4.
go back to reference Balasubramaniam G, Brown EA, Davenport A, Cairns H, Cooper B, Fan SLS, et al. The Pan-Thames EPS study: treatment and outcomes of encapsulating peritoneal sclerosis. Nephrol Dial Transplant. 2009;24(10):3209–15.CrossRef Balasubramaniam G, Brown EA, Davenport A, Cairns H, Cooper B, Fan SLS, et al. The Pan-Thames EPS study: treatment and outcomes of encapsulating peritoneal sclerosis. Nephrol Dial Transplant. 2009;24(10):3209–15.CrossRef
5.
go back to reference Shroff R, Stefanidis CJ, Askiti V, Edefonti A, Testa S, Ekim M, et al. Encapsulating peritoneal sclerosis in children on chronic PD: a survey from the European Paediatric Dialysis Working Group. Nephrol Dial Transplant. 2013;28(7):1908–14.CrossRef Shroff R, Stefanidis CJ, Askiti V, Edefonti A, Testa S, Ekim M, et al. Encapsulating peritoneal sclerosis in children on chronic PD: a survey from the European Paediatric Dialysis Working Group. Nephrol Dial Transplant. 2013;28(7):1908–14.CrossRef
7.
go back to reference Stefanidis CJ, Shroff R. Encapsulating peritoneal sclerosis in children. Pediatr Nephrol. 2014;29(11):2093–103.CrossRef Stefanidis CJ, Shroff R. Encapsulating peritoneal sclerosis in children. Pediatr Nephrol. 2014;29(11):2093–103.CrossRef
9.
go back to reference Woodrow G, Augustine T, Brown EA, Cowling M, El-Sherbini N, Hurst H, et al. UK encapsulating peritoneal sclerosis clinical practice guidelines. Petersfield, UK Ren Assoc. 2009. Woodrow G, Augustine T, Brown EA, Cowling M, El-Sherbini N, Hurst H, et al. UK encapsulating peritoneal sclerosis clinical practice guidelines. Petersfield, UK Ren Assoc. 2009.
10.
go back to reference Augustine T, Brown PW, Davies SD, Summers AM, Wilkie ME. Encapsulating peritoneal sclerosis: clinical significance and implications. Nephron Clin Pract. 2009;111(2):c149–54.CrossRef Augustine T, Brown PW, Davies SD, Summers AM, Wilkie ME. Encapsulating peritoneal sclerosis: clinical significance and implications. Nephron Clin Pract. 2009;111(2):c149–54.CrossRef
12.
go back to reference Vidal E, Edefonti A, Puteo F, Chimenz R, Gianoglio B, Lavoratti G, et al. Encapsulating peritoneal sclerosis in paediatric peritoneal dialysis patients: the experience of the Italian Registry of Pediatric Chronic Dialysis. Nephrol Dial Transplant. 2013;28(6):1603–9.CrossRef Vidal E, Edefonti A, Puteo F, Chimenz R, Gianoglio B, Lavoratti G, et al. Encapsulating peritoneal sclerosis in paediatric peritoneal dialysis patients: the experience of the Italian Registry of Pediatric Chronic Dialysis. Nephrol Dial Transplant. 2013;28(6):1603–9.CrossRef
13.
go back to reference Phelan PJ, Walshe JJ, Al-Aradi A, Garvey JP, Finnegan K, O’Kelly P, et al. Encapsulating peritoneal sclerosis: experience of a tertiary referral center. Ren Fail. 2010;32(4):459–63.CrossRef Phelan PJ, Walshe JJ, Al-Aradi A, Garvey JP, Finnegan K, O’Kelly P, et al. Encapsulating peritoneal sclerosis: experience of a tertiary referral center. Ren Fail. 2010;32(4):459–63.CrossRef
14.
go back to reference Kim BS, Choi HY, Ryu DR, Yoo TH, Park HC, Kang SW, et al. Clinical characteristics of dialysis related sclerosing encapsulating peritonitis: multi-center experience in Korea. Yonsei Med J. 2005;46(1):104–11.CrossRef Kim BS, Choi HY, Ryu DR, Yoo TH, Park HC, Kang SW, et al. Clinical characteristics of dialysis related sclerosing encapsulating peritonitis: multi-center experience in Korea. Yonsei Med J. 2005;46(1):104–11.CrossRef
16.
go back to reference Goodlad C, Brown EA. Encapsulating peritoneal sclerosis: what have we learned? In: Seminars in nephrology. 2011. p. 183–98. Goodlad C, Brown EA. Encapsulating peritoneal sclerosis: what have we learned? In: Seminars in nephrology. 2011. p. 183–98.
17.
go back to reference Moinuddin Z, Summers A, van Dellen D, Augustine T, Herrick SE. Encapsulating peritoneal sclerosis—a rare but devastating peritoneal disease. Front Physiol. 2015;6(1):1–11. Moinuddin Z, Summers A, van Dellen D, Augustine T, Herrick SE. Encapsulating peritoneal sclerosis—a rare but devastating peritoneal disease. Front Physiol. 2015;6(1):1–11.
18.
go back to reference Braun N, Alscher MD, Kimmel M, Amann K, Büttner M. Encapsulating peritoneal sclerosis—an overview. Nephrol Ther. 2011;7(3):162–71.CrossRef Braun N, Alscher MD, Kimmel M, Amann K, Büttner M. Encapsulating peritoneal sclerosis—an overview. Nephrol Ther. 2011;7(3):162–71.CrossRef
19.
go back to reference Habib SM, Betjes MGH, Fieren MWJA, Boeschoten EW, Abrahams AC, Boer WH, et al. Management of encapsulating peritoneal sclerosis: a guideline on optimal and uniform treatment. Neth J Med. 2011;69(11):500–7.PubMed Habib SM, Betjes MGH, Fieren MWJA, Boeschoten EW, Abrahams AC, Boer WH, et al. Management of encapsulating peritoneal sclerosis: a guideline on optimal and uniform treatment. Neth J Med. 2011;69(11):500–7.PubMed
20.
go back to reference Ekim M, Fitöz S, Yagmurlu A, Ensari A, Yüksel S, Acar B, et al. Encapsulating peritoneal sclerosis in paediatric peritoneal dialysis patients. Nephrology. 2005;10(4):341–3.CrossRef Ekim M, Fitöz S, Yagmurlu A, Ensari A, Yüksel S, Acar B, et al. Encapsulating peritoneal sclerosis in paediatric peritoneal dialysis patients. Nephrology. 2005;10(4):341–3.CrossRef
21.
go back to reference Hoshii S, Honda M, Itami N, Oh S, Matsumura C, Moriya S, et al. Sclerosing encapsulating peritonitis in pediatric peritoneal dialysis patients. Pediatr Nephrol. 2000;14(4):275–9.CrossRef Hoshii S, Honda M, Itami N, Oh S, Matsumura C, Moriya S, et al. Sclerosing encapsulating peritonitis in pediatric peritoneal dialysis patients. Pediatr Nephrol. 2000;14(4):275–9.CrossRef
22.
go back to reference Araki Y, Hataya H, Tanaka Y, Fukuzawa R, Ikeda M, Kawamura K, et al. Long-term peritoneal dialysis is a risk factor of sclerosing encapsulating peritonitis for children. Perit Dial Int. 2000;20(4):445–51.CrossRef Araki Y, Hataya H, Tanaka Y, Fukuzawa R, Ikeda M, Kawamura K, et al. Long-term peritoneal dialysis is a risk factor of sclerosing encapsulating peritonitis for children. Perit Dial Int. 2000;20(4):445–51.CrossRef
23.
go back to reference Campbell S, Clarke P, Hawley C, Wigan M, Kerlin P, Butler J, et al. Sclerosing peritonitis: identification of diagnostic, clinical, and radiological features. Am J Kidney Dis. 1994;24(5):819–25.CrossRef Campbell S, Clarke P, Hawley C, Wigan M, Kerlin P, Butler J, et al. Sclerosing peritonitis: identification of diagnostic, clinical, and radiological features. Am J Kidney Dis. 1994;24(5):819–25.CrossRef
24.
go back to reference Nakao M, Yamamoto I, Maruyama Y, Morishita M, Nakashima A, Matsuo N, et al. Risk factors for encapsulating peritoneal sclerosis: analysis of a 36-year experience in a University Hospital. Nephrology. 2017;22(11):907–12.CrossRef Nakao M, Yamamoto I, Maruyama Y, Morishita M, Nakashima A, Matsuo N, et al. Risk factors for encapsulating peritoneal sclerosis: analysis of a 36-year experience in a University Hospital. Nephrology. 2017;22(11):907–12.CrossRef
25.
go back to reference Williams JD, Craig KJ, Topley N, Williams GT. Peritoneal dialysis: changes to the structure of the peritoneal membrane and potential for biocompatible solutions. Kidney Int Suppl. 2003;63(84):158–61.CrossRef Williams JD, Craig KJ, Topley N, Williams GT. Peritoneal dialysis: changes to the structure of the peritoneal membrane and potential for biocompatible solutions. Kidney Int Suppl. 2003;63(84):158–61.CrossRef
26.
go back to reference Fieren MWJA, Betjes MGH, Korte MR, Boer WH. Posttransplant encapsulating peritoneal sclerosis: a worrying new trend? Perit Dial Int. 2007;27(6):619–24.CrossRef Fieren MWJA, Betjes MGH, Korte MR, Boer WH. Posttransplant encapsulating peritoneal sclerosis: a worrying new trend? Perit Dial Int. 2007;27(6):619–24.CrossRef
27.
go back to reference Kuriyama S, Tomonari H. Corticosteroid therapy in encapsulating peritoneal sclerosis. Nephrol Dial Transplant. 2001;16(6):1304–5.CrossRef Kuriyama S, Tomonari H. Corticosteroid therapy in encapsulating peritoneal sclerosis. Nephrol Dial Transplant. 2001;16(6):1304–5.CrossRef
28.
go back to reference Lafrance JP, Létourneau I, Ouimet D, Bonnardeaux A, Leblanc M, Mathieu N, et al. Successful treatment of encapsulating peritoneal sclerosis with immunosuppressive therapy. Am J Kidney Dis. 2008;51(2):7–10.CrossRef Lafrance JP, Létourneau I, Ouimet D, Bonnardeaux A, Leblanc M, Mathieu N, et al. Successful treatment of encapsulating peritoneal sclerosis with immunosuppressive therapy. Am J Kidney Dis. 2008;51(2):7–10.CrossRef
29.
go back to reference Wong CF, Beshir S, Khalil A, Pai P, Ahmad R. Successful treatment of encapsulating peritoneal sclerosis with azathioprine and prednisolone. Perit Dial Int. 2005;25(3):285–7.CrossRef Wong CF, Beshir S, Khalil A, Pai P, Ahmad R. Successful treatment of encapsulating peritoneal sclerosis with azathioprine and prednisolone. Perit Dial Int. 2005;25(3):285–7.CrossRef
Metadata
Title
Clinical improvement of encapsulating peritoneal sclerosis after challenging course and 6 months of total parenteral nutrition in child with nephronophthisis: a case report
Authors
Saeed Mohammed AlZabali
Abdulkarim AlAnazi
Khawla A. Rahim
Hassan Y. Faqeehi
Publication date
01-12-2021
Publisher
BioMed Central
Published in
Journal of Medical Case Reports / Issue 1/2021
Electronic ISSN: 1752-1947
DOI
https://doi.org/10.1186/s13256-021-02905-3

Other articles of this Issue 1/2021

Journal of Medical Case Reports 1/2021 Go to the issue